The use of mobile health care units that distribute ART and PrEP medications increased uptake among people who inject drugs, ...

The University of KwaZulu-Natal (UKZN) is set to host a crucial engagement session on Friday, April 5, focusing on a ...

Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.

If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in ...

The clinical trial, dubbed FRESH and conducted in Durban, South Africa, revealed that four out of 20 women with acute HIV ...

Uncertainties caused by the threat of tariffs (implied or about to be implemented), and a slew of other minor reasons, had spooked the markets somewhat, with the S&P 500 index down more than 4% ...

THURSDAY, March 20, 2025 (HealthDay News) — For household contacts of individuals with COVID-19, taking ensitrelvir within 72 hours of symptoms is effective at preventing infection and generally well ...

Akech’s plight mirrors that of many widows in the Lango sub-region, who have been deprived of their land and livelihoods by relatives and opportunistic land grabbers. Police data indicates that ...

The trial conducted in Durban, South Africa, showed that 20 per cent of participants remain off ART and are virally suppressed after one-and-a-half years, according to a press statement from the ...

The Conference on Retroviruses and Opportunistic Infections 2025 (CROI) featured multiple sessions that focused on breaking research and treatments. The Conference on Retroviruses and ...